Peter M Thompson

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. doi request reprint Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS)
    Peter M Thompson
    Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78290 3900, USA
    Psychiatry Res 175:221-6. 2010
  2. pmc Concordance of psychiatric symptom ratings between a subject and informant, relevancy to post-mortem research
    P M Thompson
    Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX, USA
    Transl Psychiatry 3:e214. 2013
  3. doi request reprint Serotonin receptor, SERT mRNA and correlations with symptoms in males with alcohol dependence and suicide
    P M Thompson
    Department of Psychiatry, University of Texas Health Science Center San Antonio Southwest Brain Bank, USA
    Acta Psychiatr Scand 126:165-74. 2012
  4. ncbi request reprint SNAP-25 reduction in the hippocampus of patients with schizophrenia
    Peter M Thompson
    Mood and Anxiety Disorders Division, Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Code 7792, San Antonio, TX 78229 3900, USA
    Prog Neuropsychopharmacol Biol Psychiatry 27:411-7. 2003
  5. ncbi request reprint Elevated cerebrospinal fluid SNAP-25 in schizophrenia
    Peter M Thompson
    Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
    Biol Psychiatry 53:1132-7. 2003
  6. ncbi request reprint Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders
    Carmina G Bernardo
    University of Texas Health Science Center at San Antonio, Center for Bipolar Intervention in the Hispanic Community, Division of Mood and Anxiety Disorders, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Expert Opin Drug Saf 7:435-45. 2008
  7. doi request reprint A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans, LA, USA
    J Clin Psychiatry 72:1405-12. 2011
  8. ncbi request reprint Malic enzyme 2 and susceptibility to psychosis and mania
    Byung Dae Lee
    Psychiatric Genetics Research Center, Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    Psychiatry Res 150:1-11. 2007
  9. pmc Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder
    Jodi M Gonzalez
    University of Texas Health Science Center, San Antonio, TX, USA
    Patient Prefer Adherence 5:333-41. 2011
  10. ncbi request reprint Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis
    Philip Washbourne
    Department of Neurosciences, University of New Mexico Health Science Center, Albuquerque, New Mexico 87131, USA
    Nat Neurosci 5:19-26. 2002

Collaborators

Detail Information

Publications10

  1. doi request reprint Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS)
    Peter M Thompson
    Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78290 3900, USA
    Psychiatry Res 175:221-6. 2010
    ..Despite the common occurrence of anxiety in BD, it has not been identified in most prior factor analyses, in part due to limited coverage of anxiety symptoms in the source scales...
  2. pmc Concordance of psychiatric symptom ratings between a subject and informant, relevancy to post-mortem research
    P M Thompson
    Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX, USA
    Transl Psychiatry 3:e214. 2013
    ..These data suggest, with some limitations, that both retrospective and informant obtained information can provide useful clinical information in post-mortem research...
  3. doi request reprint Serotonin receptor, SERT mRNA and correlations with symptoms in males with alcohol dependence and suicide
    P M Thompson
    Department of Psychiatry, University of Texas Health Science Center San Antonio Southwest Brain Bank, USA
    Acta Psychiatr Scand 126:165-74. 2012
    ..Second, we assessed the relationship of lifetime impulsivity and mood symptoms with prefrontal cortex 5-HT measures...
  4. ncbi request reprint SNAP-25 reduction in the hippocampus of patients with schizophrenia
    Peter M Thompson
    Mood and Anxiety Disorders Division, Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Code 7792, San Antonio, TX 78229 3900, USA
    Prog Neuropsychopharmacol Biol Psychiatry 27:411-7. 2003
    ..These data add to evidence suggesting that in schizophrenia the molecular pathology of the hippocampus involves presynaptic components...
  5. ncbi request reprint Elevated cerebrospinal fluid SNAP-25 in schizophrenia
    Peter M Thompson
    Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
    Biol Psychiatry 53:1132-7. 2003
    ..In this study, we explored SNAP-25 level and clinical variables in a new group of subjects...
  6. ncbi request reprint Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders
    Carmina G Bernardo
    University of Texas Health Science Center at San Antonio, Center for Bipolar Intervention in the Hispanic Community, Division of Mood and Anxiety Disorders, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Expert Opin Drug Saf 7:435-45. 2008
    ..These manifestations complicate the illness and worsen prognosis. Pharmacological treatment options may be limited by the primary neurological illness and side effects...
  7. doi request reprint A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans, LA, USA
    J Clin Psychiatry 72:1405-12. 2011
    ..This study is the largest double-blind placebo-controlled study conducted to date of lamotrigine in this role...
  8. ncbi request reprint Malic enzyme 2 and susceptibility to psychosis and mania
    Byung Dae Lee
    Psychiatric Genetics Research Center, Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    Psychiatry Res 150:1-11. 2007
    ..The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder...
  9. pmc Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder
    Jodi M Gonzalez
    University of Texas Health Science Center, San Antonio, TX, USA
    Patient Prefer Adherence 5:333-41. 2011
    ..Asenapine is approved for acute manic and mixed states in bipolar disorder. The objective is to review the efficacy of asenapine in bipolar disorder, with a particular focus on acceptability and adherence to treatment...
  10. ncbi request reprint Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis
    Philip Washbourne
    Department of Neurosciences, University of New Mexico Health Science Center, Albuquerque, New Mexico 87131, USA
    Nat Neurosci 5:19-26. 2002
    ..These results demonstrate that the development of neurotransmission requires the recruitment of a specialized SNARE core complex to meet the demands of regulated exocytosis...